Freenome, Inc. (FRNM)
NASDAQ: FRNM · Real-Time Price · USD
9.99
-0.07 (-0.70%)
At close: Jul 30, 2026, 4:00 PM EDT
10.30
+0.31 (3.10%)
After-hours: Jul 30, 2026, 5:13 PM EDT
Freenome Revenue
Freenome had revenue of $4.22M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $34.24M. In the year 2025, Freenome had annual revenue of $30.41M with 955.14% growth.
Revenue (ttm)
$34.24M
Revenue Growth
+955.14%
P/S Ratio
33.49
Revenue / Employee
$94,317
Employees
363
Market Cap
1.13B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.41M | 27.53M | 955.14% |
| Dec 31, 2024 | 2.88M | 780.00K | 37.11% |
| Dec 31, 2023 | 2.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionFRNM News
- 3 days ago - FDA approves Freenome's blood test for colorectal cancer screening - Reuters
- 3 days ago - FDA Approves Freenome's SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S. - GlobeNewsWire
- 10 days ago - Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection - GlobeNewsWire